| Literature DB >> 27505355 |
Agnes Binagwaho1,2,3, Ida Kankindi1, Eugenie Kayirangwa4, Jean Pierre Nyemazi1, Sabin Nsanzimana1, Fernando Morales5, Rose Kadende-Kaiser4, Kirstin Woody Scott2, Veronicah Mugisha6, Ruben Sahabo6, Cyprien Baribwira7, Leia Isanhart7, Anita Asiimwe1, Wafaa M El-Sadr6, Pratima L Raghunathan8.
Abstract
Agnes Binagwaho and colleagues describe how Rwanda achieved country ownership of its HIV programs.Entities:
Mesh:
Year: 2016 PMID: 27505355 PMCID: PMC4978459 DOI: 10.1371/journal.pmed.1002075
Source DB: PubMed Journal: PLoS Med ISSN: 1549-1277 Impact factor: 11.069
Fig 1Total PEPFAR approved funding to Rwanda for HIV, tuberculosis (TB)/HIV, and health systems strengthening, 2004–2013.
Sources: FY2004–2011: http://www.pepfar.gov/documents/organization/199598.pdf; 2012: http://www.pepfar.gov/documents/organization/212155.pdf; 2013: http://www.pepfar.gov/documents/organization/222179.pdf. FY, Fiscal Year.
Key HIV Program Indicators in Rwanda, 2005–2013.
| HIV Program Indicator | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 |
|---|---|---|---|---|---|---|---|---|---|
| Number of individuals who received testing and counseling services for HIV and received their results | 687,656 | 895,324 | 1,272,848 | 1,503,503 | 1,938,507 | 2,400,731 | 3,134,423 | 3,633,647 | 3,940,775 |
| Percentage of adult population aged 15–49 years who reported having received an HIV test in the last 12 months | (DHS 2005) 11.6% women, 11.0% men | (DHS 2010) 38% women, 37.7% men | |||||||
| Percentage of pregnant women living with HIV who received ART for PMTCT (%) | 56 | 71 | 82 | 84 | 70 | 68 | 79 | 90 | 92 |
| Percentage of HIV-infected persons eligible for antiretroviral treatment who received it (%) | 45.5 | 69.1 | 82.2 | 65.3 | 75.8 | 83.3 | 89.3 | 91.5 | 92.0 |
Source: Data obtained from Tracnet and the 2005 and 2010 Rwanda Demographic and Health Surveys (DHSs). ART, antiretroviral therapy.
a Reduction from 2008–2009 due to guideline changes and phased implementation of option B, B+ for Prevention of Mother to Child HIV Transmission (PMTCT);
b Reduction from 2007–2008 due to increased number of people in need of ART (denominator) resulting from change of national immunologic eligibility criteria from less than 200 to less than 350 cells/mm3 cluster of differentiation 4 (CD4) count.